Are the guidelines for treatment of myocardial infarction complied with?

Insights

Many patients with non-ST elevation myocardial infarction (NSTEMI) did not receive timely treatment. Direct admission to hospitals with percutaneous coronary intervention (PCI) capabilities is recommended for acute myocardial infarction cases.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • New guidelines advocate for early invasive evaluation and treatment for acute myocardial infarction (AMI) patients, including those with myocardial infarction without ST elevation (NSTEMI).
  • This study assesses adherence to these guidelines at Sørlandet Hospital Arendal.

Purpose of the Study:

  • To examine compliance with new AMI guidelines at Sørlandet Hospital Arendal.
  • To analyze the timeliness of diagnosis and treatment for AMI patients.

Main Methods:

  • Data from the Norwegian Myocardial Infarction Register for patients admitted in 2012 were analyzed.
  • Time from symptom onset to coronary angiography and revascularization was calculated for ST-elevation myocardial infarction (STEMI) and NSTEMI patients.

Main Results:

  • Of 788 AMI patients, 269 had STEMI and 519 had NSTEMI.
  • STEMI patients had a median revascularization time of 31 minutes.
  • Only 1.2% of transferred NSTEMI patients received angiography within two hours of initial admission; 34.3% received it within 24 hours.

Conclusions:

  • A significant number of NSTEMI patients did not undergo revascularization within the recommended timeframe.
  • Direct admission to PCI-equipped hospitals is crucial for suspected acute myocardial infarction cases to improve treatment times.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
398
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
565
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
493
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753